Thomas Frazier Ii
Chief Science Officer at Autism Speaks
Thomas Frazier, Ph.D., joined Autism Speaks in April 2017 as chief science officer. He is responsible for the science portfolio, including grantmaking, the MSSNG genomic research project and the Autism Treatment Network. As a clinical psychologist, Dr. Frazier has been involved for 11 years in evaluation, treatment and research focused on individuals with autism. Prior to joining Autism Speaks, he was the director of the Cleveland Clinic Center for Autism and an assistant professor of pediatrics at the Cleveland Clinic Lerner College of Medicine. Over the past decade, Dr. Frazier has published more than 100 peer-reviewed papers and done numerous conference presentations. His research has focused on improving autism identification; developing and studying new treatment approaches; creating and refining measures for tracking autism symptoms and quality of life in individuals and families affected by autism; and translational studies of a genetic sub-group of individuals with autism and phosphatase and tensin homolog (PTEN) mutations.
Chief Science Officer